The structural impact of a polyglutamine tract is location-dependent

Biophysical Journal

Volumn 95, Issue 12, 2008, Pages 5922-5930

  Robertson, Amy L ^a   Horne, James ^b   Ellisdon, Andrew M ^a   Thomas, Bronwen ^a   Scanlon, Martin J ^b   Bottomley, Stephen P ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; POLYGLUTAMINE; STAPHYLOCOCCUS PROTEIN A;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; LONG TERMINAL REPEAT; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; THERMODYNAMICS;

MODELS, MOLECULAR; MUTATION; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STAPHYLOCOCCAL PROTEIN A; TERMINAL REPEAT SEQUENCES; THERMODYNAMICS;

EID: 58749112388     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.108.138487     Document Type: Article

References (50)

1. Dobson, C. M. 2004. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 15:3-16.
2. Ross, C. A., and M. A. Poirier. 2005. Opinion: what is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6:891-898.
3. Soto, C. 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4:49-60.
4. Chen, S., F. A. Ferrone, and R. Wetzel. 2002. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA. 99:11884-11889.
5. Scherzinger, E., A. Sittler, K. Schweiger, V. Heiser, R. Lurz, R. Hasenbank, G. P. Bates, H. Lehrach, and E. E. Wanker. 1999. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA. 96:4604-4609.
6. Yang, W., J. R. Dunlap, R. B. Andrews, and R. Wetzel. 2002. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11:2905-2917.
7. Wanker, E. E. 2000. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol. Chem. 381:937-942.
8. Duennwald, M. L., S. Jagadish, F. Giorgini, P. J. Muchowski, and S. Lindquist. 2006. A network of protein interactions determines polyglutamine toxicity. Proc. Natl. Acad. Sci. USA. 103:11051-11056.
9. Duennwald, M. L., S. Jagadish, P. J. Muchowski, and S. Lindquist. 2006. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. USA. 103:11045-11050.
10. Nozaki, K., O. Onodera, H. Takano, and S. Tsuji. 2001. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport. 12:3357-3364.
11. Rockabrand, E., N. Slepko, A. Pantalone, V. N. Nukala, A. Kazantsev, J. L. Marsh, P. G. Sullivan, J. S. Steffan, S. L. Sensi, and L. M. Thompson. 2007. The first 17 amino acids of huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16:61-77.
12. Chai, Y., L. Wu, J. D. Griffin, and H. L. Paulson. 2001. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J. Biol. Chem. 276:44889-44897.
13. Cooper, J. K., G. Schilling, M. F. Peters, W. J. Herring, A. H. Sharp, Z. Kaminsky, J. Masone, F. A. Khan, M. Delanoy, D. R. Borchelt, V. L. Dawson, T. M. Dawson, and C. A. Ross. 1998. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7:783-790.
14. Haacke, A., S. A. Broadley, R. Boteva, N. Tzvetkov, F. U. Hartl, and P. Breuer. 2006. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum. Mol. Genet. 15:555-568.
15. Li, M., E. S. Chevalier-Larsen, D. E. Merry, and M. I. Diamond. 2007. Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J. Biol. Chem. 282:3157-3164.
16. Perutz, M. F. 1999. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24:58-63.
17. Chow, M. K., A. M. Ellisdon, L. D. Cabrita, and S. P. Bottomley. 2004. Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease. J. Biol. Chem. 279:47643-47651.
18. Chow, M. K., H. L. Paulson, and S. P. Bottomley. 2004. Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J. Mol. Biol. 335:333-341.
19. Ignatova, Z., and L. M. Gierasch. 2006. Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent β barrel protein. J. Biol. Chem. 281:12959-12967.
20. Tanaka, M., I. Morishima, T. Akagi, T. Hashikawa, and N. Nukina. 2001. Intra- and intermolecular β-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases. J. Biol. Chem. 276:45470-45475.
21. Chow, M. K., J. P. Mackay, J. C. Whisstock, M. J. Scanlon, and S. P. Bottomley. 2004. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem. Biophys. Res. Commun. 322:387-394.
22. Masino, L., G. Nicastro, R. P. Menon, F. Dal Piaz, L. Calder, and A. Pastore. 2004. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J. Mol. Biol. 344:1021-1035.
23. Bhattacharyya, A., A. K. Thakur, V. M. Chellgren, G. Thiagarajan, A. D. Williams, B. W. Chellgren, T. P. Creamer, and R. Wetzel. 2006. Oligoproline effects on polyglutamine conformation and aggregation. J. Mol. Biol. 355:524-535.
24. Faux, N. G., S. P. Bottomley, A. M. Lesk, J. A. Irving, J. R. Morrison, M. G. de la Banda, and J. C. Whisstock. 2005. Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res. 15:537-551.
25. Cabrita, L. D., W. Dai, and S. P. Bottomley. 2006. A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production. BMC Biotechnol. 6:12.
26. Peters, M. F., and C. A. Ross. 1999. Preparation of human cDNas encoding expanded polyglutamine repeats. Neurosci. Lett. 275:129-132.
27. Studier, F. W. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.
28. Marley, J., M. Lu, and C. Bracken. 2001. A method for efficient isotopic labeling of recombinant proteins. J. Biomol. NMR. 20:71-75.
29. Lobley, A., L. Whitmore, and B. A. Wallace. 2002. DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics. 18:211-212.
30. Nagai, Y., T. Tucker, H. Ren, D. J. Kenan, B. S. Henderson, J. D. Keene, W. J. Strittmatter, and J. R. Burke. 2000. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J. Biol. Chem. 275:10437-10442.
31. Ellisdon, A. M., B. Thomas, and S. P. Bottomley. 2006. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J. Biol. Chem. 281:16888-16896.
32. Sattler, M., J. Schleucher, and C. Griesinger. 1999. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Magn. Reson. Spectrosc. 34:93-158.
33. Kay, L. E., P. Keifer, and P. Saarinen. 1992. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114:10663-10665.
34. Delaglio, F., S. Grzesiek, G. W. Vuister, G. Zhu, J. Pfeifer, and A. Bax. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:277-293.
35. Herrmann, T., P. Guntert, and K. Wuthrich. 2002. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319:209-227.
36. Cornilescu, G., F. Delaglio, and A. Bax. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 13:289-302.
37. Schwieters, C. D., J. J. Kuszewski, N. Tjandra, and G. M. Clore. 2003. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160:65-73.
38. Hwang, T. L., P. C. van Zijl, and S. Mori. 1998. Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J. Biomol. NMR. 11:221-226.
39. Bottomley, S. P., A. G. Popplewell, M. Scawen, T. Wan, B. J. Sutton, and M. G. Gore. 1994. The stability and unfolding of an IgG binding protein based upon the B domain of protein A from Staphylococcus aureus probed by tryptophan substitution and fluorescence spectroscopy. Protein Eng. 7:1463-1470.
40. Sato, S., T. L. Religa, V. Daggett, and A. R. Fersht. 2004. Testing protein-folding simulations by experiment: B domain of protein A. Proc. Natl. Acad. Sci. USA. 101:6952-6956.
41. Torigoe, H., I. Shimada, A. Saito, M. Sato, and Y. Arata. 1990. Sequential 1H NMR assignments and secondary structure of the B domain of staphylococcal protein A: structural changes between the free B domain in solution and the Fc-bound B domain in crystal. Biochemistry. 29:8787-8793.
42. Klein, F. A., A. Pastore, L. Masino, G. Zeder-Lutz, H. Nierengarten, M. Oulad-Abdelghani, D. Altschuh, J. L. Mandel, and Y. Trottier. 2007. Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient. J. Mol. Biol. 371:235-244.
43. Ellisdon, A. M., M. C. Pearce, and S. P. Bottomley. 2007. Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J. Mol. Biol. 368:595-605.
44. Snell, R. G., J. C. MacMillan, J. P. Cheadle, I. Fenton, L. P. Lazarou, P. Davies, M. E. MacDonald, J. F. Gusella, P. S. Harper, and D. J. Shaw. 1993. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4:393-397.
45. Ladurner, A. G., and A. R. Fersht. 1997. Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates. J. Mol. Biol. 273:330-337.
46. Booth, D. R., M. Sunde, V. Bellotti, C. V. Robinson, W. L. Hutchinson, P. E. Fraser, P. N. Hawkins, C. M. Dobson, S. E. Radford, C. C. Blake, and M. B. Pepys. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 385:787-793.
47. Hammarstrom, P., X. Jiang, A. R. Hurshman, E. T. Powers, and J. W. Kelly. 2002. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc. Natl. Acad. Sci. USA. 99(Suppl 4):16427-16432.
48. Horwich, A. 2002. Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. J. Clin. Invest. 110:1221-1232.
49. Liemann, S., and R. Glockshuber. 1999. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry. 38:3258-3267.
50. Swietnicki, W., R. B. Petersen, P. Gambetti, and W. K. Surewicz. 1998. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273:31048-31052.